Antibody deficiency in Rubinstein-Taybi syndrome

R Herriot, Z Miedzybrodzka

Research output: Contribution to journalArticle

1 Citation (Scopus)
2 Downloads (Pure)

Abstract

The developmental disorder Rubinstein-Taybi syndrome (RTS) is frequently complicated by recurrent respiratory infections. In many cases this is likely to be the result of microaspiration or gastro-oesophageal reflux but, in a proportion, underlying antibody deficiency is a potentially modifiable susceptibility factor for infection. Relatively subtle, specific defects of pneumococcal antibody production have previously been described in the context of RTS. Here, we report a rare association between the syndrome and an overt, major primary antibody deficiency disorder (common variable immune deficiency) which was successfully managed with immunoglobulin replacement therapy. Early recognition and investigation for antibody deficiency associated with RTS allied to effective and optimized treatment are essential to minimize morbidity and mortality and improve quality and duration of life.

Original languageEnglish
Pages (from-to)355-358
Number of pages4
JournalClinical Genetics
Volume89
Issue number3
Early online date28 Sep 2015
DOIs
Publication statusPublished - Mar 2016

Fingerprint

Rubinstein-Taybi Syndrome
Antibodies
Common Variable Immunodeficiency
Passive Immunization
Gastroesophageal Reflux
Respiratory Tract Infections
Antibody Formation
Quality of Life
Morbidity
Mortality
Infection
Therapeutics

Keywords

  • antibody deficiency
  • immunoglobulin replacement therapy
  • Rubinstein-Taybi syndrome

Cite this

Antibody deficiency in Rubinstein-Taybi syndrome. / Herriot, R; Miedzybrodzka, Z.

In: Clinical Genetics, Vol. 89, No. 3, 03.2016, p. 355-358.

Research output: Contribution to journalArticle

Herriot, R ; Miedzybrodzka, Z. / Antibody deficiency in Rubinstein-Taybi syndrome. In: Clinical Genetics. 2016 ; Vol. 89, No. 3. pp. 355-358.
@article{8d82106da490459c9563176f273e8d29,
title = "Antibody deficiency in Rubinstein-Taybi syndrome",
abstract = "The developmental disorder Rubinstein-Taybi syndrome (RTS) is frequently complicated by recurrent respiratory infections. In many cases this is likely to be the result of microaspiration or gastro-oesophageal reflux but, in a proportion, underlying antibody deficiency is a potentially modifiable susceptibility factor for infection. Relatively subtle, specific defects of pneumococcal antibody production have previously been described in the context of RTS. Here, we report a rare association between the syndrome and an overt, major primary antibody deficiency disorder (common variable immune deficiency) which was successfully managed with immunoglobulin replacement therapy. Early recognition and investigation for antibody deficiency associated with RTS allied to effective and optimized treatment are essential to minimize morbidity and mortality and improve quality and duration of life.",
keywords = "antibody deficiency, immunoglobulin replacement therapy, Rubinstein-Taybi syndrome",
author = "R Herriot and Z Miedzybrodzka",
note = "{\circledC} 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2016",
month = "3",
doi = "10.1111/cge.12671",
language = "English",
volume = "89",
pages = "355--358",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Antibody deficiency in Rubinstein-Taybi syndrome

AU - Herriot, R

AU - Miedzybrodzka, Z

N1 - © 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

PY - 2016/3

Y1 - 2016/3

N2 - The developmental disorder Rubinstein-Taybi syndrome (RTS) is frequently complicated by recurrent respiratory infections. In many cases this is likely to be the result of microaspiration or gastro-oesophageal reflux but, in a proportion, underlying antibody deficiency is a potentially modifiable susceptibility factor for infection. Relatively subtle, specific defects of pneumococcal antibody production have previously been described in the context of RTS. Here, we report a rare association between the syndrome and an overt, major primary antibody deficiency disorder (common variable immune deficiency) which was successfully managed with immunoglobulin replacement therapy. Early recognition and investigation for antibody deficiency associated with RTS allied to effective and optimized treatment are essential to minimize morbidity and mortality and improve quality and duration of life.

AB - The developmental disorder Rubinstein-Taybi syndrome (RTS) is frequently complicated by recurrent respiratory infections. In many cases this is likely to be the result of microaspiration or gastro-oesophageal reflux but, in a proportion, underlying antibody deficiency is a potentially modifiable susceptibility factor for infection. Relatively subtle, specific defects of pneumococcal antibody production have previously been described in the context of RTS. Here, we report a rare association between the syndrome and an overt, major primary antibody deficiency disorder (common variable immune deficiency) which was successfully managed with immunoglobulin replacement therapy. Early recognition and investigation for antibody deficiency associated with RTS allied to effective and optimized treatment are essential to minimize morbidity and mortality and improve quality and duration of life.

KW - antibody deficiency

KW - immunoglobulin replacement therapy

KW - Rubinstein-Taybi syndrome

U2 - 10.1111/cge.12671

DO - 10.1111/cge.12671

M3 - Article

VL - 89

SP - 355

EP - 358

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

IS - 3

ER -